M. A. Dimopoulos Et Al. , "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.," 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , vol.116, Florida, United States Of America, pp.1247-1248, 2010
Dimopoulos, M. A. Et Al. 2010. Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.. 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , (Florida, United States Of America), 1247-1248.
Dimopoulos, M. A., De Samblanx, H. M., Roussou, M. G., Zervas, K., Katodritou, E., Sargin, D., ... Hulin, C.(2010). Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study. . 52nd Annual Meeting of the American-Society-of-Hematology (ASH) (pp.1247-1248). Florida, United States Of America
Dimopoulos, Meletios Et Al. "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.," 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 2010
Dimopoulos, Meletios A. Et Al. "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.." 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , Florida, United States Of America, pp.1247-1248, 2010
Dimopoulos, M. A. Et Al. (2010) . "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.." 52nd Annual Meeting of the American-Society-of-Hematology (ASH) , Florida, United States Of America, pp.1247-1248.
@conferencepaper{conferencepaper, author={Meletios A. Dimopoulos Et Al. }, title={Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.}, congress name={52nd Annual Meeting of the American-Society-of-Hematology (ASH)}, city={Florida}, country={United States Of America}, year={2010}, pages={1247-1248} }